Menopause can be a challenging transition, with symptoms like hot flashes, night sweats, and sleep disturbances affecting millions of women. Until now, most effective treatments have involved hormone therapy—a solution that isn’t right for everyone. In a significant step forward, the FDA has just approved elinzanetant, a new, non-hormonal medication designed specifically to relieve moderate to severe vasomotor symptoms (like hot flashes) associated with menopause.
What Is Elinzanetant?
Elinzanetant is a first-in-class, non-hormonal therapy that works by targeting neurokinin receptors in the brain—key players in the body’s temperature regulation. Unlike traditional hormone replacement therapy, elinzanetant does not contain estrogen or progestin, making it an important new option for women who cannot or prefer not to use hormones.
Why This Approval Matters
- Broader Access: Many women have contraindications to hormone therapy, or simply want non-hormonal choices. Elinzanetant offers effective symptom relief without hormones.
- Safety Profile: Clinical trials have shown that elinzanetant is well-tolerated and significantly reduces the frequency and severity of hot flashes.
- Empowering Women: With more choices, women can work with their healthcare providers to find the treatment that best fits their needs and preferences
What Does This Mean for You?
If you’re experiencing bothersome menopause symptoms and haven’t found relief, or if you’ve been hesitant about hormone therapy, elinzanetant could be a promising new option. As always, it’s important to discuss your symptoms and medical history with a knowledgeable provider.
How My Virtual Physician Can Help
At My Virtual Physician, our board-certified gynecologists and women’s health specialists stay up-to-date on the latest advancements in menopause care. We’re here to help you understand your options—including whether elinzanetant might be right for you. Our virtual visits make it easy to get expert guidance from the comfort of your home, no matter where you are in the U.S.
Ready to talk about menopause and your treatment options?
